908 Devices (MASS) | Stock Overview & Key Data
908 Devices Performance Comparison
Stock Range
Today's Range
Low: $6.20
High: $6.41
on August 28, 2025
52 Week Range
Low: $1.81
High: $8.06
on December 24, 2024
on June 20, 2025
All-Time High: $79.60 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$227.3M
EPS
-2.36
P/E Ratio (TTM)
-2.95
Forward P/E
-5.89
P/B Ratio
1.53
PEG Ratio
-5.89
Div. Yield
N/A
ROE
-53.40%
Beta
0.370
Debt to Equity
2.98
Financial Highlights
Profitability
Gross Margin
48.89%
Operating Margin
-64.20%
Profit Margin
-28.13%
Returns and Earnings
Return on Assets (TTM)
-15.39%
Return on Equity (TTM)
-53.40%
EBITDA
$-44.2M
Net Income (TTM)
$-81.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.87
Quarterly Revenue Growth (YoY)
13.70%
Quarterly Earnings Growth (YoY)
-7.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| 908 Devices MASS | 227.34M Micro-cap | 3.99% | -14.60% | 5.03% | 179.46% | 185.84% | 58.48% | -64.31% | -87.61% |
| Abbott Laboratories ABT | 228.57B Mega-cap | -0.48% | 3.97% | -0.49% | -4.81% | 15.81% | 15.98% | 28.17% | 26.12% |
| Boston Scientific BSX | 157.64B Large-cap | 0.51% | -0.09% | 1.19% | 1.89% | 18.32% | 29.29% | 161.18% | 154.94% |
| Outset Medical OM | 243.75M Micro-cap | 1.83% | -22.84% | -28.62% | 27.47% | -20.68% | 75.09% | -94.47% | -98.45% |
| Cerus CERS | 250.17M Small-cap | 9.17% | -3.68% | 3.97% | -20.61% | -16.56% | -42.04% | -66.58% | -77.45% |
| Quantum-Si QSI | 230.84M Micro-cap | 3.60% | -35.75% | -35.39% | -16.67% | -73.19% | 21.05% | -62.42% | -88.36% |
Ownership & Short Interest
Insider Ownership
8.37%
Institutional Ownership
83.29%
Shares Short
2M
Short Ratio
6.70
Short % of Shares Outstanding
11.32%
Average 10-Day Volume
224K
Average 90-Day Volume
275K
908 Devices Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in 908 Devices would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MASS's 52-week high and low?
- In the last 52 weeks, 908 Devices reached a high of $8.06 (on June 20, 2025) and a low of $1.81 (on December 24, 2024).
- What is the market cap and P/E ratio for MASS?
- Curious about 908 Devices's size and valuation? Its market capitalization stands at 227.34M. When it comes to valuation, the P/E ratio (trailing twelve months) is -2.95, and the forward P/E (looking ahead) is -5.89.
- Does MASS pay dividends? If so, what's the yield?
- As for dividends, 908 Devices isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are 908 Devices's main competitors or similar companies to consider before investing?
When looking at 908 Devices, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT228.57B Healthcare Medical Devices 15.98% 28.17% Boston Scientific
BSX157.64B Healthcare Medical Devices 29.29% 161.18% Outset Medical
OM243.75M Healthcare Medical Devices 75.09% -94.47% Cerus
CERS250.17M Healthcare Medical Devices -42.04% -66.58% Quantum-Si
QSI230.84M Healthcare Medical Devices 21.05% -62.42% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for 908 Devices Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of 908 Devices's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -53.40%, the Debt to Equity ratio from the most recent quarter is 2.98, and its Gross Profit Margin stands at 48.89%.
- What is the recent revenue and earnings growth for MASS?
- Looking at 908 Devices's growth, its revenue over the trailing twelve months (TTM) was $66M. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.70%, and quarterly earnings saw a YoY growth of -7.20%.
- How much of MASS stock is held by insiders and institutions?
- Wondering who owns 908 Devices stock? Company insiders (like executives and directors) hold about 8.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 83.29%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.